Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 months ago

Possible Interaction: Nitric Oxide and Asymmetric Dimethylarginine

Research Papers that Mention the Interaction

The correlation between the decrease of ADMA and increase of NO subsequent to weight loss was significant (P < 0.0001).
Annals of clinical biochemistry  •  2012  |  View Paper
Elevated plasma levels of asymmetric dimethylarginine ( ADMA) inhibit nitric oxide formation and exert a proatherogenic action.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme  •  2008  |  View Paper
Moreover, ADMA , l‐NMMA and l‐leucine were effective inhibitors of NO synthesis in both hypertensive and control platelets.
Clinical and experimental pharmacology & physiology  •  2007  |  View Paper
To the … inhibitor of nitric oxide (NO) synthase3,4 that has been recently associated independently with increased cardiovascular event rates.5 Nocturnal hemodialysis (NHD) (5 to 6 … glyceryl trinitrate (GTN) is enhanced.7 ADMA inhibits competitively all 3 isoforms of NO synthase.8 When infused into healthy humans, ADMA …
Arteriosclerosis, thrombosis, and vascular biology  •  2005  |  View Paper
Infusion of ADMA caused a significant decrease in plasma cyclic guanosine monophosphate (cGMP) levels, i.e. the second messenger of NO (from 6.1 ± 0.4 to 4.3 ± 0.3 pmol/l; p < 0.05).
Kidney and Blood Pressure Research  •  2004  |  View Paper
In addition, significant negative correlations were detected between the plasma concentration of nitric oxide and the plasma concentration of homocysteine (r=-0.592, P<0.0001) and ADMA (r=-0.789, P<0.0001).
Neurobiology of Aging  •  2003  |  View Paper
As NO synthesis can be antagonized by its endogenous inhibitor asymmetric dimethyl L-arginine (ADMA), we determined ADMA plasma concentrations, which were elevated at baseline in comparison to healthy middle-aged individuals (3.9 6 0.2 versus 1.0 6 0.1 mmol/l; p, 0.0001).
Vascular medicine  •  2003  |  View Paper
ADMA is a potent inhibitor of NO synthesis, and accumulates in the plasma of patients with renal failure.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association  •  1996  |  View Paper
Although asymmetrical dimethyl arginine , an inhibitor of nitric oxide , has been shown to be associated with progression of renal disease, symmetric dimethyl arginine may be a better marker.
Advances in clinical chemistry  •  2019  |  View Paper
AIM Asymmetric dimethylarginine ADMA ) is involved in the regulation of nitric oxide synthesis and in the maintenance of vascular tone and structure.
Clinical biochemistry  •  2017  |  View Paper
Show More